Pharmarise HoldingsPharmarise Holdings Corporation2796東証スタンダードサービス業FY ending May 2026, consolidated, J-GAAP
Out of every ¥100 of sales, about ¥2 is left as operating profit. Revenue changed +9.5% from the prior year, operating profit +234.1%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | 0.9% | 2.17× | 1.9% | 3.71× | 7.0% |
| 2023 | 0.6% | 2.21× | 1.4% | 3.61× | 5.1% |
| 2024 | — | —× | -1.3% | —× | — |
| 2025 | — | —× | -1.2% | —× | — |
| 2026 | 0.2% | 2.15× | 0.4% | 4.90× | 1.7% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
| Item | FY ending May 2022 | FY ending May 2023 | FY ending May 2024 | FY ending May 2025 | FY ending May 2026 |
|---|---|---|---|---|---|
| Revenue | 51,608 | 52,030 | 54,466 | 63,508 | 69,512 |
| Cost of revenue | 43,491 | 43,896 | 46,017 | 54,542 | 60,053 |
| Gross profit | 8,117 | 8,134 | 8,449 | 8,965 | 9,459 |
| SG&A | 6,596 | 6,695 | 7,533 | 8,671 | 8,479 |
| Operating income | 1,520 | 1,438 | 916 | 293 | 979 |
| Pretax income | 1,322 | 1,049 | 143 | 8 | 698 |
| Income tax | 864 | 702 | 485 | 390 | 591 |
| Net income attributable to owners | 447 | 333 | -351 | -367 | 114 |
| Operating margin | 2.9% | 2.8% | 1.7% | 0.5% | 1.4% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending May 2022 | FY ending May 2023 | FY ending May 2024 | FY ending May 2025 | FY ending May 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥3.99B | ¥4.73B | ¥7.1B | ¥4.89B | ¥6.01B |
| Total assets | ¥23.7B | ¥23.4B | ¥29.5B | ¥31.9B | ¥32.7B |
| Net assets | ¥6.7B | ¥6.99B | ¥7.44B | ¥6.92B | ¥6.86B |
| Share capital | ¥1.27B | ¥1.3B | ¥1.96B | ¥1.96B | ¥1.96B |
| Property, plant and equipment | ¥6.36B | ¥6.01B | ¥6.2B | ¥7.21B | ¥7.62B |
| Intangible assets excluding goodwill | ¥3.63B | ¥3.25B | ¥6.42B | ¥7.27B | ¥7.6B |
| Goodwill | ¥3.22B | ¥2.75B | ¥5.92B | ¥6.8B | ¥7.26B |
| Investment securities | ¥60M | ¥82M | ¥67M | ¥339M | ¥339M |
| Current assets | ¥10.9B | ¥11.4B | ¥13.7B | ¥13.2B | ¥13.2B |
| Current liabilities | ¥8.48B | ¥9.84B | ¥10.7B | ¥12B | ¥14B |
| Long-term borrowings | ¥5.6B | ¥5.22B | ¥9.65B | ¥11.1B | ¥9.81B |
| Bonds | ¥1.48B | — | — | — | — |
| Total liabilities | ¥17B | ¥16.4B | ¥22B | ¥25B | ¥25.8B |
| Non-controlling interests | ¥91M | ¥105M | ¥80M | ¥49M | ¥17M |
| Equity attributable to owners of parent | ¥6.41B | ¥6.66B | ¥7.12B | ¥6.61B | ¥6.57B |
| Retained earnings | ¥3.81B | ¥4.01B | ¥3.53B | ¥2.94B | ¥2.89B |
| Treasury stock | -¥210M | -¥210M | -¥550M | -¥471M | -¥376M |
EDINET (FSA Japan)
有価証券報告書－第40期(2025/06/01－2026/05/31)
EDINET (FSA Japan)
有価証券報告書－第39期(2024/06/01－2025/05/31)
EDINET (FSA Japan)
有価証券報告書－第38期(2023/06/01－2024/05/31)
EDINET (FSA Japan)
有価証券報告書－第37期(2022/06/01－2023/05/31)
EDINET (FSA Japan)
有価証券報告書－第36期(令和3年6月1日－令和4年5月31日)
EDINET (FSA Japan)
有価証券報告書－第35期(令和2年6月1日－令和3年5月31日)
Extracted from XBRL: 51 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.